Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours

References

• Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004; 303: 1818–1822
   PubMed Web of Science ®Google Scholar
• Drummond DC, Zignani M, Leroux JC. Current status of pH-sensitive liposomes in drug delivery. Progress in Lipid Research 2000; 39: 409–460
   PubMed Web of Science ®Google Scholar
• Jensen SS, Andresen TL, Davidsen J, Hoyrup P, Shnyder SD, Bibby MC, Gill JH, Jorgensen K. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol Cancer Ther 2004; 3: 1451–1458
   PubMed Web of Science ®Google Scholar
• Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, Dellian M. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res 2004; 10: 2168–2178
   PubMed Web of Science ®Google Scholar
• Hossann M, Wiggenhorn M, Schwerdt A, Wachholz K, Teichert N, Eibl H, Issels RD, Lindner LH. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta 2007; 1768: 2491–2499
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978; 202: 1290–1293
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000; 60: 1197–1201
   PubMed Web of Science ®Google Scholar
• Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: A novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009; 10: 333–343
   PubMed Web of Science ®Google Scholar
• Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000; 6: 3748–3755
   PubMed Web of Science ®Google Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15: 345–370
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Anyarambhatla GR, Needham D. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: A new temperature-sensitive liposome for use with mild hyperthermia. J Liposome Res 1999; 9: 491–506
   Web of Science ®Google Scholar
• Mills JK, Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta Oct 15, 2005; 1716(2)77–96
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: Review of animal and human studies. Clin Pharmacokinet 2003; 42: 419–436
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60: 6950–6957
   PubMed Web of Science ®Google Scholar
• Chen Q, Tong S, Dewhirst MW, Yuan F. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther 2004; 3: 1311–1317
   PubMed Web of Science ®Google Scholar
• Chen Q, Krol A, Wright A, Needham D, Dewhirst MW, Yuan F. Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia 2008; 24: 475–482
   PubMed Web of Science ®Google Scholar
• Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, Pruitt AF, Klein A, Case B, Thrall DE, et al. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 2006; 12: 4004–4010
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 2000. A phase I dose escalation tolerability study of ThermoDox™ (thermally sensitive liposomal doxorubicin) in combination with radiofrequency ablation (RFA) of primary and metastatic tumors of the liver; 2007. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00441376 (accessed 14 February 2010)
   Google Scholar
• ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 2000. A phase I dose escalation study of heat activated liposome delivery of doxorubicin and radiofrequency ablation of primary and metastatic tumors of the liver; 2004. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00093444 (accessed 14 February 2010)
   Google Scholar
• ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 2000. A phase III, randomized, double-blinded, dummy-controlled study of the efficacy and safety of ThermoDox® (thermally sensitive liposomal doxorubicin) in combination with radiofrequency ablation (RFA) compared to RFA alone in the treatment of non-resectable hepatocellular carcinoma; 2008. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00617981 (accessed 14 February 2010)
   Google Scholar
• ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). 2000. A phase I, dose escalation and pharmacokinetics study of temperature sensitive liposome encapsulated doxorubicin(ThermoDox™) and hyperthermia in patients with local-regionally recurrent breast cancer; 2006. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00346229?term=ThermoDox&rank=4 (accessed 14 February 2010)
   Google Scholar
• Mayer LD, Bally MB, Cullis PR. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 1986; 857: 123–126
   PubMed Web of Science ®Google Scholar
• Madden TD, Harrigan PR, Tai LC, Bally MB, Mayer LD, Redelmeier TE, Loughrey HC, Tilcock CP, Reinish LW, Cullis PR. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: A survey. Chem Phys Lipids 1990; 53: 37–46
   PubMed Web of Science ®Google Scholar
• Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, Bally MB. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 1989; 49: 5922–5930
   PubMed Web of Science ®Google Scholar
• Wright A. Drug Loading And Release from Thermally Sensitive Liposome. Duke University, Durham, NC 2006
   Google Scholar
• Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, Bally MB, Dewhirst MW. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magnetic Resonance in Medicine 2004; 51: 1153–1162
   PubMed Web of Science ®Google Scholar
• DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978; 235: E97–102
   PubMed Web of Science ®Google Scholar
• Prescott DM, Charles HC, Sostman HD, Page RL, Thrall DE, Moore D, Oleson JR, Dewhirst MW. Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int J Hyperthermia 1993; 9: 745–754
   PubMed Web of Science ®Google Scholar
• Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, Chevrette M, Aprikian A, Chevalier S. Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Mol Cell Endocrinol 2000; 159: 63–77
   PubMed Web of Science ®Google Scholar
• Aslakson CJ, Rak JW, Miller BE, Miller FR. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis. Int J Cancer 1991; 47: 466–472
   PubMed Web of Science ®Google Scholar
• NCI/NIH Developmental Therapeutics Program DS. NCI/NIH Developmental Therapeutics Program, Discovery Series. NCI/NIH; 2010. Available from: http://dtp.nci.nih.gov/docs/misc/common_files/cell_list.html (accessed 14 February 2010)
   Google Scholar
• Perez LA, Dombkowski D, Efird J, Preffer F, Suit HD. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: A study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements. Cancer Res 1995; 55: 392–398
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Ritter MA, Fowler JF, Kinsella TJ. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. Int J Radiat Oncol Biol Phys 1994; 29: 105–113
   PubMed Web of Science ®Google Scholar
• Jones E, Alvarez Secord A, Prosnitz LR, Samulski TV, Oleson JR, Berchuck A, Clarke-Pearson D, Soper J, Dewhirst MW, Vujaskovic Z. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. Int J Hyperthermia 2006; 22: 161–172
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
   PubMed Web of Science ®Google Scholar
• Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005; 181: 35–41
   PubMed Web of Science ®Google Scholar
• Working PK, Newman MS, Huang SK, Mayhew E, Vaage J, Lasic DD. Pharmacokinetics, Biodistribution and Therapeutic Efficacy of Doxorubicin Encapsulated in Stealth® Liposomes (Doxil®). J Liposome Res. 1994; 4(1)667–687
   Google Scholar
• Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res Apr 15, 1994; 54(8)2186–2191
   PubMed Web of Science ®Google Scholar
• Dunn J. Doxorubicin-induced cardiomyopathy. J Pediatr Oncol Nurs 1994; 11: 152–160
   PubMedGoogle Scholar
• Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994; 54: 4564–4568
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60: 4440–4445
   PubMed Web of Science ®Google Scholar
• Karino T, Koga S, Maeta M. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J Surg 1988; 18: 276–283
   PubMedGoogle Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 2001; 53: 285–305
   PubMed Web of Science ®Google Scholar
• Brown GA, McPherson JP, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer Res 1995; 55: 78–82
   PubMed Web of Science ®Google Scholar
• Giaccone G, Gazdar AF, Beck H, Zunino F, Capranico G. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 1992; 52: 1666–1674
   PubMed Web of Science ®Google Scholar
• Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijo N. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J Natl Cancer Inst 1992; 84: 113–118
   PubMed Web of Science ®Google Scholar
• Fry AM, Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, Masters JR, Hickson ID. Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 1991; 51: 6592–6595
   PubMed Web of Science ®Google Scholar
• Szulawska A, Czyz M. [Molecular mechanisms of anthracyclines action]. Postepy Hig Med Dosw 2006; 60: 78–100
   Google Scholar
• Nielsen D, Maare C, Skovsgaard T. Cellular resistance to anthracyclines. Gen Pharmacol 1996; 27: 251–255
   PubMedGoogle Scholar
• Duan Z, Feller AJ, Toh HC, Makastorsis T, Seiden MV. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. Gene 1999; 229: 75–81
   PubMed Web of Science ®Google Scholar
• Smith V, Raynaud F, Workman P, Kelland LR. Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol. Mol Pharmacol 2001; 60: 885–893
   PubMed Web of Science ®Google Scholar
• van Brussel JP, van Steenbrugge GJ, Romijn JC, Schroder FH, Mickisch GH. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer 1999; 35: 664–671
   PubMed Web of Science ®Google Scholar
• El-Kareh AW, Secomb TW. Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin. Neoplasia 2005; 7: 705–713
   PubMed Web of Science ®Google Scholar
• Owen CS. Dependence of proton generation on aerobic or anaerobic metabolism and implications for tumour pH. Int J Hyperthermia 1996; 12: 495–499
   PubMed Web of Science ®Google Scholar
• Wike-Hooley JL, van den Berg AP, van der Zee J, Reinhold HS. Human tumour pH and its variation. Eur J Cancer Clin Oncol 1985; 21: 785–791
   PubMedGoogle Scholar
• Prescott DM, Charles HC, Poulson JM, Page RL, Thrall DE, Vujaskovic Z, Dewhirst MW. The relationship between intracellular and extracellular pH in spontaneous canine tumors. Clin Cancer Res 2000; 6: 2501–2505
   PubMed Web of Science ®Google Scholar
• Atema A, Buurman KJ, Noteboom E, Smets LA. Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int J Cancer 1993; 54: 166–172
   PubMed Web of Science ®Google Scholar
• Born R, Eichholtzwirth H. Effect of different physiological conditions on the action of adriamycin on Chinese hamster cells in vitro. Brit J Cancer 1981; 44: 241–246
   PubMed Web of Science ®Google Scholar
• Muzi M, Spence AM, O’Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA. Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas. J Nucl Med 2006; 47: 1612–1621
   PubMed Web of Science ®Google Scholar
• Ponce AM, Viglianti BL, Yu D, Yarmolenko PS, Michelich CR, Woo J, Bally MB, Dewhirst MW. Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst 2007; 99: 53–63
   PubMed Web of Science ®Google Scholar